The emergence of pathogens is conferring resistance to last-resort therapies such as tigecycline, colistin, and carbapenems, limiting the therapeutic options, and raising concerns about the emergence
Objective of the study was to assess AMR occurrence in Escherichia coli isolated from wild birds, followed by identification of AMR determinants and investigation of their epidemiological relationship
The occurrence of colistin resistance has increased rapidly among Enterobacterales around the world. We performed a national survey of plasmid-mediated colistin resistance in human clinical isolates t